Market Tracker

12/02 5:16pm ET

Abbott Laboratories (NYSE:ABT)

37.90
Delayed Data
As of 4:03pm ET
 +0.30 / +0.80%
Today’s Change
36.00
Today|||52-Week Range
46.22
-15.61%
Year-to-Date
MedTech Sails Through Macro Woes: Stocks in Focus
2:54pm / Zacks.com - Paid Partner Content
The Best Obamacare Stocks of 2016
Nov 29 / MotleyFool.com - Paid Partner Content
Abbott's i-STAT Alinity Received CE Mark
Nov 30 / GuruFocus News - Paid Partner Content
Big Pharma healthcare R&D steps out into the open
Nov 29 / FT.com - Paid Partner Content

Today’s Trading

Previous close37.60
Today’s open37.68
Day’s range37.60 - 38.08
Volume7,252,818
Average volume (3 months)9,013,273
Market cap$55.4B
Dividend yield2.74%
Data as of 4:03pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+18.14%
Earnings growth (this year)+2.66%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.78%
P/E ratio57.4
Price/Sales3.31
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
SHPGShire+3.82+2.23%
AZNAstraZeneca+0.08+0.31%
NVONovo Nordisk+0.38+1.13%
REGNRegeneron Pharmaceut...-2.85-0.76%
Data as of 4:02pm ET, 12/02/2016

Financials

Next reporting dateJanuary 25, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts